NOTCH1 is recurrently affected by activating mutations in about 10-20% of chronic lymphocytic leukemias and mantle cell lymphomas, and in a lower fraction of diffuse large B cell lymphomas, follicular lymphomas and splenic marginal zone lymphomas [25, 26, 29, 34, 40]. This evidence concerns the gene NOTCH1 and splenic marginal zone lymphoma.